Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-18-030106

Chief Financial Officer bought 4,000 shares at $5.77 ($23,080)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-05-15 Purchase : show line 1 in the form +4,000 $5.77 $23,080 348,010 D
Open-market purchases · 4,000 sh · avg $5.77 · $23,080
Loading xslF345X03/doc4.xml…